PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
14.27%
Net income growth of 14.27% while Healthcare median is zero at 0.00%. Walter Schloss would note a slight edge that could grow if sustained.
2.30%
D&A growth of 2.30% while Healthcare median is zero at 0.00%. Walter Schloss would question intangible or new expansions driving that cost difference.
100.00%
Deferred tax growth of 100.00% while Healthcare median is zero at 0.00%. Walter Schloss would see a difference that might matter for future cash flow if significant.
-60.58%
SBC declines yoy while Healthcare median is 0.00%. Seth Klarman would see a near-term advantage in less dilution unless new hires are needed.
97.10%
A slight increase while Healthcare median is negative at -6.97%. Peter Lynch might see peers reaping more free cash if they can do so without impacting sales.
No Data
No Data available this quarter, please select a different quarter.
100.06%
Inventory growth of 100.06% while Healthcare median is zero at 0.00%. Walter Schloss would question if expansions or new product lines require extra stock.
No Data
No Data available this quarter, please select a different quarter.
-18.36%
Other WC usage shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage if top-line is stable or growing.
-27.42%
Other non-cash items dropping yoy while Healthcare median is 0.00%. Seth Klarman would see a short-term advantage if real fundamentals remain intact.
38.10%
Positive CFO growth while Healthcare median is negative at -9.25%. Peter Lynch would see a notable cash advantage in a challenging sector environment.
-133.43%
CapEx declines yoy while Healthcare median is 0.00%. Seth Klarman would note a short-term FCF advantage if revenue is stable.
-100.00%
Acquisition spending declines yoy while Healthcare median is 0.00%. Seth Klarman would note reduced M&A risk if growth continues organically.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
93.88%
Growth of 93.88% while Healthcare median is zero at 0.00%. Walter Schloss questions intangible or special projects explaining that difference.
-14.40%
Reduced investing yoy while Healthcare median is 0.00%. Seth Klarman sees potential advantage in near-term liquidity if revenue remains stable.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We reduce issuance yoy while Healthcare median is 0.00%. Seth Klarman might see an advantage in preserving per-share value unless expansions are neglected.
No Data
No Data available this quarter, please select a different quarter.